MedPath

Trial of Enhanced Pre-Consent Discussion

Not Applicable
Completed
Conditions
Pediatric Crohn's Disease
Registration Number
NCT02869880
Lead Sponsor
Children's Hospital Medical Center, Cincinnati
Brief Summary

Nested within the COMBINE pragmatic clinical trial, the investigators will conduct a cluster randomized controlled trial to determine whether, in parents (of children with Crohn's Disease) or patients \> 18 years old being approached for trial participation, a pre-consent discussion enhanced with decision aids is more effective than the standard pre-consent discussion in transferring knowledge to parents/patients related to trial participation.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
241
Inclusion Criteria
  • Parent of a child who is eligible for the COMBINE trial (ClinicalTrials.gov Identifier: NCT02772965)
  • Patient who is eligible for the COMBINE trial (ClinicalTrials.gov Identifier: NCT02772965)
Exclusion Criteria
  • Non-English speaking

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Knowledge Related to Trial Participationprior to consent

Number correct on 5-item Knowledge Related to Trial Participation survey

Secondary Outcome Measures
NameTimeMethod
Rate of enrollmentat consent
Support subscale of decision conflict scaleprior to consent

Trial Locations

Locations (1)

Cincinnati Children's Hospital Medical Center

🇺🇸

Cincinnati, Ohio, United States

Cincinnati Children's Hospital Medical Center
🇺🇸Cincinnati, Ohio, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.